The Journal of Immunology, Vol 157, Issue 11 4892-4898, Copyright © 1996 by American Association of Immunologists

ARTICLES

DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules

CC Stebbins, ME Peterson, WM Suh and AJ Sant
University of Chicago, Department of Pathology and Committee on Immunology, IL 60637, USA.

The nonpolymorphic, nonclassical class II molecule DM has been shown to be important in the processing and presentation of antigenic epitopes by MHC class II molecules. The dependence of class II molecules on the coexpression of DM varies with the particular allele or epitope studied. In an effort to resolve disparities that exist for some alleles of class II in their requirements for DM, we have constructed a species-matched murine transfection model with which we can test both the functional and biochemical consequences of DM expression for different alleles of murine class II. When we evaluated the ability of class II molecules to form SDS-stable dimer and release CLIP, we find that while I-A(d) requires DM for the formation of SDS-stable dimers and the release of CLIP, I-A(k) is capable of both SDS-stable dimer formation and CLIP release in the absence of DM. Despite the apparent differences in the biochemical consequences of DM expression for I-A(d) and I-A(k), we find that Ag presentation by both alleles can be enhanced by the expression of DM. Interestingly, we find that DM can facilitate the removal of a natural intermediate in Ii processing (p12). The ability of DM to catalyze the dissociation of p12 and possibly larger Ii fragments from class II in vivo offers a possible mechanism to account for the observed DM enhancement of Ag presentation for alleles that have a low affinity for CLIP. Our findings indicate that DM may function in multiple compartments and on multiple class II/Ii substrates.

This article has been cited by other articles:

				J. Larkin III, A. L. Rankin, C. C. Picca, M. P. Riley, S. A. Jenks, A. J. Sant, and A. J. Caton CD4+CD25+ Regulatory T Cell Repertoire Formation Shaped by Differential Presentation of Peptides from a Self-Antigen J. Immunol., February 15, 2008; 180(4): 2149 - 2157. [Abstract] [Full Text] [PDF]

				C. A. Lazarski, F. A. Chaves, and A. J. Sant The impact of DM on MHC class II-restricted antigen presentation can be altered by manipulation of MHC-peptide kinetic stability J. Exp. Med., May 15, 2006; 203(5): 1319 - 1328. [Abstract] [Full Text] [PDF]

				D. H. Kaplan, B. E. Anderson, J. M. McNiff, D. Jain, M. J. Shlomchik, and W. D. Shlomchik Target Antigens Determine Graft-versus-Host Disease Phenotype J. Immunol., November 1, 2004; 173(9): 5467 - 5475. [Abstract] [Full Text] [PDF]

				C. H. Koonce, G. Wutz, E. J. Robertson, A. B. Vogt, H. Kropshofer, and E. K. Bikoff DM Loss in k Haplotype Mice Reveals Isotype-Specific Chaperone Requirements J. Immunol., April 1, 2003; 170(7): 3751 - 3761. [Abstract] [Full Text] [PDF]

				G. Yan, L. Shi, A. Penfornis, and D. L. Faustman Impaired Processing and Presentation by MHC Class II Proteins in Human Diabetic Cells J. Immunol., January 1, 2003; 170(1): 620 - 627. [Abstract] [Full Text] [PDF]

				E. K. Bikoff, G. Wutz, G. A. Kenty, C. H. Koonce, and E. J. Robertson Relaxed DM Requirements During Class II Peptide Loading and CD4+ T Cell Maturation in BALB/c Mice J. Immunol., April 15, 2001; 166(8): 5087 - 5098. [Abstract] [Full Text] [PDF]

				N. K. Nanda and A. J. Sant DM Determines the Cryptic and Immunodominant Fate of T Cell Epitopes J. Exp. Med., September 11, 2000; 192(6): 781 - 788. [Abstract] [Full Text] [PDF]

				N. J. Felix, W. J. Brickey, R. Griffiths, J. Zhang, L. Van Kaer, T. Coffman, and J. P.-Y. Ting H2-DM{alpha}-/- Mice Show the Importance of Major Histocompatibility Complex-bound Peptide in Cardiac Allograft Rejection J. Exp. Med., June 26, 2000; 192(1): 31 - 40. [Abstract] [Full Text] [PDF]

				A. K. Sato, J. A. Zarutskie, M. M. Rushe, A. Lomakin, S. K. Natarajan, S. Sadegh-Nasseri, G. B. Benedek, and L. J. Stern Determinants of the Peptide-induced Conformational Change in the Human Class II Major Histocompatibility Complex Protein HLA-DR1 J. Biol. Chem., January 21, 2000; 275(3): 2165 - 2173. [Abstract] [Full Text] [PDF]

				G. Kenty and E. K. Bikoff BALB/c Invariant Chain Mutant Mice Display Relatively Efficient Maturation of CD4+ T Cells in the Periphery and Secondary Proliferative Responses Elicited upon Peptide Challenge J. Immunol., July 1, 1999; 163(1): 232 - 241. [Abstract] [Full Text] [PDF]

				W. P. Thayer, L. Ignatowicz, D. A. Weber, and P. E. Jensen Class II-Associated Invariant Chain Peptide-Independent Binding of Invariant Chain to Class II MHC molecules J. Immunol., February 1, 1999; 162(3): 1502 - 1509. [Abstract] [Full Text] [PDF]

				J. Antoine, T Lang, E Prina, N Courret, and R Hellio H-2M molecules, like MHC class II molecules, are targeted to parasitophorous vacuoles of Leishmania-infected macrophages and internalized by amastigotes of L. amazonensis and L. mexicana J. Cell Sci., January 8, 1999; 112(15): 2559 - 2570. [Abstract] [PDF]

				S. Ceman, S. Wu, T. S. Jardetzky, and A. J. Sant Alteration of a Single Hydrogen Bond between Class II Molecules and Peptide Results in Rapid Degradation of Class II Molecules after Invariant Chain Removal J. Exp. Med., December 7, 1998; 188(11): 2139 - 2149. [Abstract] [Full Text] [PDF]

				R. A. Ettinger, A. W. Liu, G. T. Nepom, and W. W. Kwok Exceptional Stability of the HLA-DQA1*0102/DQB1*0602 {alpha}{beta} Protein Dimer, the Class II MHC Molecule Associated with Protection from Insulin-Dependent Diabetes Mellitus J. Immunol., December 1, 1998; 161(11): 6439 - 6445. [Abstract] [Full Text] [PDF]

				M. Peterson and A. J. Sant The Inability of the Nonobese Diabetic Class II Molecule to Form Stable Peptide Complexes Does Not Reflect a Failure to Interact Productively with DM J. Immunol., September 15, 1998; 161(6): 2961 - 2967. [Abstract] [Full Text] [PDF]

				E. K. Bikoff, G. Kenty, and L. Van Kaer Distinct Peptide Loading Pathways for MHC Class II Molecules Associated with Alternative Ii Chain Isoforms J. Immunol., April 1, 1998; 160(7): 3101 - 3110. [Abstract] [Full Text] [PDF]

				G. Ferrari, A. M. Knight, C. Watts, and J. Pieters Distinct Intracellular Compartments Involved in Invariant Chain Degradation and Antigenic Peptide Loading of Major Histocompatibility Complex (MHC) Class II Molecules J. Cell Biol., December 15, 1997; 139(6): 1433 - 1446. [Abstract] [Full Text] [PDF]

				W. Walter, C. Scheuer, M. Loos, T. E. Reichert, and M. J. Maeurer H2-Mbeta 1 and H2-Mbeta 2 Heterodimers Equally Promote CLIP Removal in I-Aq Molecules from Autoimmune-prone DBA/1 Mice J. Biol. Chem., March 30, 2001; 276(14): 11086 - 11091. [Abstract] [Full Text] [PDF]